This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Alkermes plc
11/3/2026
Greetings and welcome to the Alkermes third quarter 2026 financial results conference call. My name is Dylan and I will be your operator for today's call. All participant lines will be placed on mute to prevent background noise. If you should require operator assistance during the call, please press star zero from your telephone keypad. Please note this conference is being recorded. I will now turn the call over to Sandra Coombs, senior vice president of investor relations and corporate affairs. Sandy, you may now begin.
Welcome to the Alkermes plc conference call to discuss our financial results and business update for the quarter ended September 30th, 2026. With me today are Blair Jackson, our chief executive officer, Todd Nichols, our chief commercial officer, and Joshua Reed, our chief financial officer. A slide presentation along with our press release, related financial tables, and reconciliations of the gap to non-gap financial measures that we'll discuss today are available on the investor section of alkermes.com. We believe the non-GAAP financial results in conjunction with the GAAP results are useful in understanding the ongoing economics of our business. Our discussions during this conference call will include forward-looking statements. Actual results could differ materially from these forward-looking statements. Please see slide two of the accompanying presentation, our press release issued this morning, and our most recent annual report filed with the FCC for important risk factors that could cause our actual results to differ materially from those expressed or implied in the forward-looking statement. We undertake no obligation to update or revise the information provided on this call or in the accompanying presentation as a result of new information or future results or developments. After our prepared remarks, we'll open the call for Q&A and now I'll turn the call over to Blair for some opening remarks.
Thank you, Sandy. Good morning, everyone. My first quarterly call as CEO of Alkermes, I'd like to start with a few thoughts on the opportunity ahead and the priorities that will guide us. We have a clear strategy and a strong foundation. Our focus now is on execution. That means advancing our pipeline with rigor and urgency, driving strong commercial and financial performance, and allocating capital thoughtfully to our highest value opportunities. Our commercial business is an important element of our strategy and provides a strong financial foundation to invest in innovation. Our greatest opportunity for growth and value creation lies in our pipeline, particularly our leadership in erection research and the potential of our erection development portfolio to yield important new treatment options in neuropsychiatry. I'll discuss the significant momentum across our development pipeline in more detail following the discussion of the quarterly results. The combination of commercial strength, financial performance, and a differentiated pipeline positions Alkermes well for its next chapter and the potential for meaningful long-term value creation for shareholders. I'm incredibly proud and honored to lead Alkermes at this important point in its evolution, and I'm confident in our strategy, our people, and the opportunities ahead. With that, let's turn to the quarter, Todd.
You're reading a preview of the ALKS Q3 2026 earnings call.
Free account.
Want transcripts like this in your own app? Try the Earnings call API, or read the transcript API docs.
Use this data in your own app
Pull this call's transcript, audio and slides with the Earnings call transcripts API.
See pricing